Type 1 diabetes mellitus with stable proliferative diabetic retinopathy (right eye)
ICD-10 E10.3551 is a billable code used to indicate a diagnosis of type 1 diabetes mellitus with stable proliferative diabetic retinopathy (right eye).
E10.3551 refers to Type 1 diabetes mellitus characterized by the presence of stable proliferative diabetic retinopathy in the right eye. Type 1 diabetes is an autoimmune condition where the pancreas produces little to no insulin, leading to elevated blood glucose levels. Proliferative diabetic retinopathy (PDR) is a severe complication of diabetes, marked by the growth of new blood vessels in the retina, which can lead to vision loss. The term 'stable' indicates that the condition has not worsened, and the patient is under appropriate management. Regular monitoring of HbA1c levels is crucial, as it reflects long-term glucose control. Insulin management is essential for Type 1 diabetes, often requiring multiple daily injections or an insulin pump. Patients with PDR may also require additional interventions, such as laser therapy or anti-VEGF injections, to prevent further retinal damage. Comprehensive management includes regular eye examinations, glycemic control, and education on diabetes self-management.
Detailed records of diabetes management, including insulin regimens and HbA1c levels.
Patients presenting with uncontrolled diabetes or complications requiring insulin adjustments.
Ensure documentation reflects the patient's diabetes type and any complications.
Comprehensive eye exam reports, including findings related to diabetic retinopathy.
Patients undergoing routine eye exams for diabetic retinopathy.
Document the stability of the retinopathy and any treatments provided.
Used during routine eye exams for diabetic retinopathy.
Document findings of the eye exam, including any changes in retinopathy.
Ophthalmologists should ensure thorough documentation of diabetic complications.
'Stable' indicates that the condition has not worsened over time and that the patient is under effective management, with no new complications arising.
